 |
BO20485 |
CBS-1114 HCl |
33244-00-7 |
C13H14ClN3 |
247.7234 |
VIEW DETAILS > |
 |
BO20486 |
Alalevonadifloxacin |
2892364-59-7 |
C23H30FN3O8S |
527.563 |
VIEW DETAILS > |
 |
BO20530 |
(R)-M3913 |
2379783-61-4 |
C17H21ClN4O3S |
396.8916 |
VIEW DETAILS > |
 |
BO20487 |
Aβ-IN-1 |
2766509-32-2 |
C35H49N |
483.7703 |
VIEW DETAILS > |
 |
BO20533 |
CNS-11 |
445218-34-8 |
C25H21N3O2 |
395.4531 |
VIEW DETAILS > |
 |
BO20488 |
Cap-dependent endonuclease-IN-1 |
2365473-17-0 |
C27H22F2N2O6S |
540.5352 |
VIEW DETAILS > |
 |
BO20534 |
Mcl-1 inhibitor 17 |
892250-00-9 |
C27H25FN4O2 |
456.5114 |
VIEW DETAILS > |
 |
BO20490 |
mTOR inhibitor 9f |
1144075-42-2 |
C25H23N5O2S |
457.5474 |
VIEW DETAILS > |
 |
BO20491 |
Rel-5-(4-Chloro-2-fluorophenyl)-2,3-dimethyl-7-[(2R,4S)-tetrahydro-2-(1-methyl-1H-pyrazol-4-yl)-2H-pyran-4-yl]pyrido[3,4-b]pyrazine |
2738485-99-7 |
|
|
VIEW DETAILS > |
 |
BO20493 |
(S)-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-2-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-7-carboxamide |
1934246-20-4 |
C26H23F3N6O |
492.4956 |
VIEW DETAILS > |